Despite this correction, we emphasize that the main conclusions and context of the study remain unchanged. The observed trends in herpes zoster ophthalmicus incidence, age distribution patterns, and treatment location preferences are consistent with our original findings. The statistical significance of our key observations, including the increase in HZO patients across all age groups and the projected doubling of cases by 2040, remains robust.